￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis on the types of patients with contraindications and non-recommendations for taking Mobosetinib (Anvili)

2026-02-01 22:25:32

Check Details
Tepotinib (Tuodekang) efficacy evaluation and summary of clinical research data

2026-02-01 22:25:32

Check Details
Evaluation of the clinical efficacy of regorafenib (Belvango) and its treatment indications for different cancers

2026-02-01 22:25:32

Check Details
Price of a box of pazopanib (Viant) and market reference in different regions

2026-02-01 22:25:32

Check Details
Summary of clinical treatment effects and patient feedback of Opicapone

2026-02-01 22:25:32

Check Details
Observation summary of changes in urinary protein and efficacy of Fenelidone (Keshenda) after taking it for 6 days

2026-02-01 22:25:32

Check Details
Rasagiline (Azila) standard usage and dosage and recommended medication regimen

2026-02-01 22:25:32

Check Details
How long does the efficacy of Platinib (Pujihua) remain stable when treating diseases?

2026-02-01 22:25:32

Check Details
Recommended dosage, dosage and taking time of the targeted drug Capmatinib (Touradida)

2026-02-01 22:25:32

Check Details
Whether Sotolaxib (AMG 510) has been included in medical insurance and details of reimbursement ratio

2026-02-01 22:25:32

Check Details
Analysis of whether adagrasib (Krazati) is a chemotherapy drug and how it differs from traditional chemotherapy

2026-02-01 22:25:32

Check Details
Description of indications and clinical recommended groups of larotrectinib (Vitaika)

2026-02-01 22:25:32

Check Details
Category
相关知识